SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

      Date of Report (Date of earliest event reported): February 26, 2004

                       ROCKWELL MEDICAL TECHNOLOGIES, INC.
             (Exact name of registrant as specified in its Charter)

          Michigan                000-230-661                    38-3317208
----------------------------      -----------                    ----------
(State or other jurisdiction      (Commission                   (IRS Employer
     of incorporation)            File Number)               Identification No.)

        30142 Wixom Road, Wixom                  Michigan          48393
----------------------------------------         --------          -----
(Address of principal executive offices)                         (Zip Code)

       Registrant's telephone number, including area code (248) 960-9009

                                 Not applicable
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)



Item 9. Regulation FD Disclosure.

      On February 26, 2004, the Company issued the press release attached hereto
as Exhibit 99.1, announcing its financial results for the year and quarter ended
December 31, 2003.

Item 12. Results of Operations and Financial Condition.

      On February 26, 2004, the Company issued the press release attached hereto
as Exhibit 99.1, announcing its financial results for the year and quarter ended
December 31, 2003.

                                   SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                         ROCKWELL MEDICAL TECHNOLOGIES, INC.

Date: March 1, 2004                      By: /s/ Thomas E. Klema
                                             -----------------------------------
                                             Thomas E. Klema
                                             Its: Chief Financial Officer